The patient admitted to the hospital for pancreatic cancer 3 days due to superior belly glutted 2 months. Physical examination after admission: flat and soft abdomen, without gastrointestinal type and peristaltic wave observed, no abdominal wall varicosis, soft abdomen, without tenderness in the whole abdomen, rebound tenderness and muscular tension, liver, spleen and sub-costal as well as mass un-involved, negative shifting dullness, audible bowel sounds 4 times/min. After admission, PET-CT was conducted as follows: 1. Body and tail focus of the pancreas, considered to be malignant (high possibility of pancreatic cancer). 2. Retroperitoneal and intraperitoneal multiple enlarged lymph nodes, considered metastasis; Peritoneum, omentum majus and mesentery were thickened, local nodules, metastasis considered. Tumor between rectum and seminal vesicle, metastasis considered; Mass was visible at the liver surface and diaphragm, metastasis considered. Spleen subcapsular low density focus, metastasis considered. 3. The wall of the intestinal canal in the abdomen and pelvis is widely thickened, metastasis to be excluded. 4. Right kidney cyst. Bilateral kidney microlithiasis. Intrahepatic calcification. 5. Ascites; Pelvic effusion. Abdominal paracentesis catheterization was conducted to drain the effusion. Cytology of ascites pathology showed adenocarcinoma. Based on the medical history, physical examination and auxiliary examination, determine the clinical diagnosis: pancreatic cancer (T2N1M1) stage IV, intraperitoneal and retroperitoneal multi-lymph node metastases, peritoneum multiple metastasis, splenic metastasis, right kidney cyst, bilateral renal microlithiasis, type 2 diabetes. Fluorouracil peritoneal perfusion chemotherapy was given, currently, the patient had mild abdominal distension and discomfort of soreness-distension for both shoulders, physical examination as mentioned above, the patient and his family required systemic chemotherapy treatment, and were informed of the expenses relevant with chemotherapy, points for attention and possible adverse reactions, the patient and the family required outpatient chemotherapy, approved discharge.